World Health Organization defends Covid-19 drug study after remdesivir maker Gilead questions methodology

The World Health Organization has defended a study that sparked a debate about whether the antiviral drug remdesivir is any use in treating Covid-19.The report was based on a large-scale clinical trial of four drugs that concluded none of them helped reduce mortality or the amount of time patients spent in hospital.Gilead, the firm that makes remdesivir, has hit back at the study, questioning its methodology. “We are concerned the data from this open-label global trial has not undergone the…

WashingtonPost_bigger

How Trump’s Sudan gambit could backfire

TOI_bigger

Don’t let negligence ruin festive happiness: PM

NYT_bigger

How the F.D.A. Stood Up to the President

TheTelegraph_bigger

Coronavirus latest news: One in ten ambulance call-outs during pandemic were for mental health

WashingtonPost_bigger

How Trump’s Sudan gambit could backfire

TOI_bigger

Don’t let negligence ruin festive happiness: PM

NYT_bigger

How the F.D.A. Stood Up to the President

TheTelegraph_bigger

Coronavirus latest news: One in ten ambulance call-outs during pandemic were for mental health

SCMP_bigger

Hong Kong on standby to record eight new Covid-19 cases, all with traceable sources of infection

TheGuardian_bigger

Polluted air killing half a million babies a year across globe

WashingtonPost_bigger

Pandemic widens learning gap in education-obsessed S. Korea